MOREPENLAB2025-04-012025-06-30MOREPENLAB2025-04-012025-06-30in-capmkt:OtherExpenses1MemberMOREPENLAB2025-04-012025-06-30in-capmkt:OtherExpenses2MemberMOREPENLAB2025-04-012025-06-30in-capmkt:OtherExpenses3MemberMOREPENLAB2025-04-012025-06-30in-capmkt:OtherExpenses4MemberMOREPENLAB2025-04-012025-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss1iso4217:INRiso4217:INRxbrli:shares500288MOREPENLABNOTLISTEDINE083A01026MOREPEN LABORATORIES LIMITEDMain BoardEquity2025-04-012026-03-312025-08-062025-08-01INRLakhsQuarterlyFirst quarterSingle segmentPharmaceuticals2025-08-0611:00:002025-08-0614:30:00Not applicable2025-04-012025-06-30UnauditedConsolidated4252388000440850004296473000237708900017039900076159000552367000403780009025100083466600041413090001551640000155164000410980000410980000114066000000-658300010748300059000001133830000000109584100020.20.2000.20.21. The above results have been reviewed by the Audit Committee and approved by the Board of Directors at their meeting held on August 06, 2025. A Limited review of the same has been carried out by the Statutory Auditors. <BR> <BR> 2. The figures for the quarter ended March 31, 2025 are the balancing figures between audited figures in respect of the full financial year and the unaudited published year to date figures upto the third quarter ended December 31, 2024. The consolidated financial results includes the financials of the Company and its subsidiaries as listed in Annexure 1, except Morepen Labs-FZCO incorporated during the quarter as a wholly owned subsidiary, which is yet to start its operations. <BR> <BR> 3. Pursuant to the sale of 1.53 Crore equity shares of Dr. Morepen Limited (DML) for Rs.30.65 Crore and further fresh issue of 7.64 crore equity shares by DML to the shareholders of Groom Town Private Limited (GTPL) for acquiring 100% equity shares of GTPL for Rs.153.01 Crore, the company's shareholding in DML has come down from 80% to 19.94%. <BR> <BR> 4. The Company is engaged only one operating segment namely, Pharmaceuticals. <BR> Power and Fuel105580000Travelling Expenses61891000Selling and Distribution Expenses303964000Other Expenses363231000Others79050007905000200500005900000